TDSGF

Telo Genomics Corp. TDSGF

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode TDSGF IDXG RNVA SLDX ENZN ICBU HLYK RVVTF TGIFF CLABF
6M -12.96 % 54.93 % 9 900.00 % -52.84 % -50.24 % 161.54 % -12.22 % -55.76 % 146.51 % -99.98 %
YTD -42.05 % -58.49 % 9 900.00 % -43.02 % -76.56 % -32.00 % -12.22 % 40.38 % 112.00 % -99.98 %
1Y -37.25 % -60.71 % 9 900.00 % -43.02 % -80.82 % -54.05 % -32.19 % 19.67 % 107.84 % -99.99 %
3Y -80.78 % 66.67 % 100.00 % -69.38 % -83.45 % 325.00 % -73.67 % -92.70 % -4.50 % -100.00 %
5Y -83.90 % -68.57 % -100.00 % -97.45 % -82.94 % 183.33 % -86.26 % -98.64 % -79.71 % -100.00 %
10Y -83.90 % -97.56 % -87.50 % -97.45 % -95.06 % 325.00 % -95.49 % -98.33 % -93.38 % -100.00 %
From the beginning -83.90 % -99.95 % -99.99 % -97.45 % -96.94 % -100.00 % -95.49 % -98.61 % -93.38 % -100.00 %

Dividend

Enzon Pharmaceuticals, Inc.